Development flow

• PoC①Development of subunit vaccines(for animals and humans)
• PoC②Application to mRNA/DNA vaccine development
• PoC③Use of monoclonal antibodies(for therapeutic and testing purposes)
• PoC(Proof of Concept)The process of determining whether it is feasible to put it into practical use.

  Specifically, the stage at which private companies, consortiums, etc. can take over research and development, and the stage at which it is possible to move into the development phase, such as NEDO projects, etc. can be established.

The efficacy at the cellular level will be conducted on campus up to the stage where the efficacy at the cellular level is confirmed by neutralization experiments. Neutralizing capacity experiments currently being conducted in the collaboration will be conducted on campus, except for experiments requiring safety level P3. Samples with confirmed efficacy at the cellular level can be licensed for collaborate research with pharmaceutical companies.